Araştırma Makalesi
BibTex RIS Kaynak Göster

The Measurement of Neutrophil Gelatinase Associated Lipocalin in Umbilical Cord Blood and the Assessment of Its Relationship with Neonatal Results

Yıl 2022, Cilt: 49 Sayı: 2, 308 - 314, 13.06.2022
https://doi.org/10.5798/dicletip.1128915

Öz

Kaynakça

  • 1.American Society of Nephrology American Societyof Nephrology Renal Research Report. J Am SocNephrol 2005; 16: 1886–93.
  • 2.Bellos, I., Fitrou, G., Daskalakis, G. et al. Neutrophilgelatinase-associated lipocalin as predictor of acutekidney injury in neonates with perinatal asphyxia: asystematic review and meta-analysis. Eur J Pediatr.2018; 177: 1425-34.
  • 3.De Mul A, Parvex P, Wilhelm-Bals A. Neutrophilgelatinase-associated lipocalin distribution inpreterm newborns without acute kidney injury asdefined by a reference method. J Matern FetalNeonatal Med. 2021; 17; 1-5.
  • 4.Parravicini E, Nemerofsky SL, Michelson KA, et al.Urinary neutrophil gelatinase-associated lipocalin is a promising biomarker for late onset culture-positive sepsis in very low birth weight infants.Pediatr Res. 2010; 67: 636-40.

The Measurement of Neutrophil Gelatinase Associated Lipocalin in Umbilical Cord Blood and the Assessment of Its Relationship with Neonatal Results

Yıl 2022, Cilt: 49 Sayı: 2, 308 - 314, 13.06.2022
https://doi.org/10.5798/dicletip.1128915

Öz

Objectives: In this study, the relationship of cord blood Neutrophil Gelatinase-Associated Lipocalin (NGAL) with neonatal diseases was investigated.
Methods: NGAL levels were measured in the cord blood of 180 babies born between 2015 and 2016. Patients were classified according to maternal diseases, neonatal diseases and demographic characteristics. Obtained data were compared with cord blood NGAL levels.
Results: In our study, the mean NGAL levels were 1283.99 ng/mL in boys and 1306.52 ng/mL in girls. Umbilical cord blood NGAL levels of infants diagnosed with intrauterine growth retardation (1913.4±2833.5 ng/mL) and prolonged premature rupture of membranes (2594.2±2037.1 ng/mL) were found to be statistically high (p<0.05). There was no statistically significant difference between NGAL levels in infants of mothers with gestational diabetes mellitus, acyanotic congenital heart diseases, meconium aspiration syndrome, infants of mothers with preeclampsia, Apgar scores and infants of mothers with oligohydramnios (p>0.05).
Conclusions: Neutrophil Gelatinase-Associated Lipocalin, may be useful as a diagnostic biomarker in the evaluation of maternal and neonatal diseases. However, studies on larger patient populations are needed.

Kaynakça

  • 1.American Society of Nephrology American Societyof Nephrology Renal Research Report. J Am SocNephrol 2005; 16: 1886–93.
  • 2.Bellos, I., Fitrou, G., Daskalakis, G. et al. Neutrophilgelatinase-associated lipocalin as predictor of acutekidney injury in neonates with perinatal asphyxia: asystematic review and meta-analysis. Eur J Pediatr.2018; 177: 1425-34.
  • 3.De Mul A, Parvex P, Wilhelm-Bals A. Neutrophilgelatinase-associated lipocalin distribution inpreterm newborns without acute kidney injury asdefined by a reference method. J Matern FetalNeonatal Med. 2021; 17; 1-5.
  • 4.Parravicini E, Nemerofsky SL, Michelson KA, et al.Urinary neutrophil gelatinase-associated lipocalin is a promising biomarker for late onset culture-positive sepsis in very low birth weight infants.Pediatr Res. 2010; 67: 636-40.
Toplam 4 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Original Articles
Yazarlar

Seckin İlter Bu kişi benim

Sabahattin Ertugrul Bu kişi benim

İbrahim Deger Bu kişi benim

İbrahim Kaplan Bu kişi benim

Yayımlanma Tarihi 13 Haziran 2022
Gönderilme Tarihi 22 Kasım 2021
Yayımlandığı Sayı Yıl 2022 Cilt: 49 Sayı: 2

Kaynak Göster

APA İlter, S., Ertugrul, S., Deger, İ., Kaplan, İ. (2022). The Measurement of Neutrophil Gelatinase Associated Lipocalin in Umbilical Cord Blood and the Assessment of Its Relationship with Neonatal Results. Dicle Tıp Dergisi, 49(2), 308-314. https://doi.org/10.5798/dicletip.1128915
AMA İlter S, Ertugrul S, Deger İ, Kaplan İ. The Measurement of Neutrophil Gelatinase Associated Lipocalin in Umbilical Cord Blood and the Assessment of Its Relationship with Neonatal Results. diclemedj. Haziran 2022;49(2):308-314. doi:10.5798/dicletip.1128915
Chicago İlter, Seckin, Sabahattin Ertugrul, İbrahim Deger, ve İbrahim Kaplan. “The Measurement of Neutrophil Gelatinase Associated Lipocalin in Umbilical Cord Blood and the Assessment of Its Relationship With Neonatal Results”. Dicle Tıp Dergisi 49, sy. 2 (Haziran 2022): 308-14. https://doi.org/10.5798/dicletip.1128915.
EndNote İlter S, Ertugrul S, Deger İ, Kaplan İ (01 Haziran 2022) The Measurement of Neutrophil Gelatinase Associated Lipocalin in Umbilical Cord Blood and the Assessment of Its Relationship with Neonatal Results. Dicle Tıp Dergisi 49 2 308–314.
IEEE S. İlter, S. Ertugrul, İ. Deger, ve İ. Kaplan, “The Measurement of Neutrophil Gelatinase Associated Lipocalin in Umbilical Cord Blood and the Assessment of Its Relationship with Neonatal Results”, diclemedj, c. 49, sy. 2, ss. 308–314, 2022, doi: 10.5798/dicletip.1128915.
ISNAD İlter, Seckin vd. “The Measurement of Neutrophil Gelatinase Associated Lipocalin in Umbilical Cord Blood and the Assessment of Its Relationship With Neonatal Results”. Dicle Tıp Dergisi 49/2 (Haziran 2022), 308-314. https://doi.org/10.5798/dicletip.1128915.
JAMA İlter S, Ertugrul S, Deger İ, Kaplan İ. The Measurement of Neutrophil Gelatinase Associated Lipocalin in Umbilical Cord Blood and the Assessment of Its Relationship with Neonatal Results. diclemedj. 2022;49:308–314.
MLA İlter, Seckin vd. “The Measurement of Neutrophil Gelatinase Associated Lipocalin in Umbilical Cord Blood and the Assessment of Its Relationship With Neonatal Results”. Dicle Tıp Dergisi, c. 49, sy. 2, 2022, ss. 308-14, doi:10.5798/dicletip.1128915.
Vancouver İlter S, Ertugrul S, Deger İ, Kaplan İ. The Measurement of Neutrophil Gelatinase Associated Lipocalin in Umbilical Cord Blood and the Assessment of Its Relationship with Neonatal Results. diclemedj. 2022;49(2):308-14.